Dishman Carbogen Amcis Ltd (DCAL) Financial Research

Dishman Carbogen Amcis Ltd operates a dual business model, combining Contract Research and Manufacturing Services (CRAMS) for pharmaceutical clients with the production of its own marketable molecules, including specialty chemicals, vitamins, and disinfectants. Its manufacturing footprint spans Switzerland, the UK, Europe, and China, positioning it as a mid-sized, vertically integrated player in the global pharma value chain. The company’s competitive edge lies in its ability to offer both custom synthesis and scalable commercial manufacturing, catering to the outsourcing needs of innovator drug companies.

Current Price: INR 259.0

Price Change: -1.56%

None